How Wegovy V Mounjaro Doses Compare For Online Prescription
Understanding Wegovy V Mounjaro Doses Through Online Prescription Services
The fundamental difference between Wegovy v Mounjaro doses lies in their mechanisms and escalation schedules. Wegovy (semaglutide) follows a 5-step dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. Mounjaro (tirzepatide) uses a different 4-step approach: 2.5mg (weeks 1-4), 5mg (weeks 5-8), 10mg (weeks 9-12), with optional escalation to 15mg if needed. Both require mandatory dose escalation—you cannot skip steps or start at higher doses.
Online prescription services like EverydayMeds streamline access to both treatments through comprehensive clinical assessments. Our licensed UK prescribers evaluate your medical history, current BMI, contraindications, and weight-related comorbidities to determine suitability. The assessment covers previous weight management attempts, current medications, and any conditions that might affect treatment choice. This thorough evaluation ensures you receive the most appropriate medication and starting dose for your individual circumstances, all without the need for face-to-face GP appointments or specialist referrals.
Wegovy V Mounjaro Doses: Pricing And Value Comparison
Wegovy pricing at EverydayMeds reflects the dose escalation schedule: 0.25mg starter dose costs £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg (£209.99). Our Getting Started bundles provide convenient dose progressions—the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is £189.99. New customers apply discount code FIRST40 at checkout, with returning customers using DOSE25. These prices include prescriber consultation, clinical review, and next-day cold-chain delivery.
Bundle options provide Reliable Supply continuity without repeated ordering. The Intro Trio (0.25mg, 0.5mg & 1mg) offers three months of initial escalation for £299.99, whilst our Ultimate Stability Trio provides three months of maintenance 2.4mg doses for £649.99. Take-It-Slow bundles accommodate patients requiring extended dose stabilisation—the Gentle Start Trio includes two 0.25mg pens plus one 0.5mg pen for £269.99. All pricing represents final checkout costs with appropriate discount codes applied, ensuring transparent, no-surprise billing for your weight management journey.
Clinical Evidence Comparing Wegovy V Mounjaro Doses
Wegovy's clinical efficacy was demonstrated in the STEP trial programme, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise (Wilding et al., NEJM, 2021). The STEP 2 trial specifically examined patients with type 2 diabetes, showing approximately 9.6% weight reduction with the 2.4mg maintenance dose. These results reflect the GLP-1 receptor agonist mechanism working on appetite centres in the brain.
Mounjaro's dual GIP and GLP-1 receptor agonist mechanism was evaluated in separate clinical programmes with different study designs and patient populations. Direct comparison of percentage weight loss between trials is not scientifically valid due to varying endpoints, baseline characteristics, and methodologies. Both medications require prescription-only access and ongoing medical supervision throughout treatment, ensuring appropriate monitoring and dose adjustments based on individual response and tolerance.
How Wegovy Works: Understanding The Wegovy V Mounjaro Doses Mechanism
Wegovy contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a natural hormone produced in your intestines after eating. This hormone signals to your brain's appetite centres, promoting feelings of fullness and satisfaction after smaller meals. The medication may also slow gastric emptying, helping food remain in your stomach longer and extending satiety between meals. Additionally, Wegovy may reduce food cravings and the psychological drive to eat, particularly for high-calorie foods. The once-weekly injection provides consistent hormone levels, supporting sustained appetite regulation throughout your weight management programme alongside dietary changes and increased physical activity.
Online Prescription Process For Wegovy V Mounjaro Doses
EverydayMeds' 3-minute clinical assessment covers essential medical information including current BMI, previous weight loss attempts, existing medications, and relevant health conditions. The assessment evaluates contraindications such as personal or family history of thyroid cancer, multiple endocrine neoplasia syndrome, or severe gastrointestinal disease. Our licensed UK prescribers review every application within standard 3 working days, with express 24-hour review available for urgent cases. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics. This streamlined process eliminates traditional barriers like GP appointments, specialist referrals, or lengthy waiting times whilst maintaining rigorous clinical standards through our GPhC-registered pharmacy (#9012878).
Storage Advantages: Wegovy V Mounjaro Doses Practical Considerations
Wegovy offers superior storage flexibility compared to Mounjaro, maintaining stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration. Mounjaro requires refrigeration return within 21 days, making Wegovy more convenient for travel or situations where consistent refrigeration isn't assured. Both medications use pre-filled injection pens—Wegovy's FlexTouch pen delivers precise doses with an easy-to-read dose counter. Standard storage requires refrigeration between 2-8°C before first use, with protection from light and freezing. The extended room temperature stability makes Wegovy particularly suitable for people with variable schedules, frequent travel, or shared refrigeration concerns, whilst maintaining full therapeutic potency throughout the dose escalation schedule.
Personalised Wegovy V Mounjaro Doses Selection Through Online Assessment
The online prescription process allows detailed evaluation of factors that influence treatment choice between Wegovy and Mounjaro doses. Your prescriber considers medical history including diabetes status, cardiovascular conditions, previous GLP-1 experience, and specific weight management goals. Individual tolerance patterns, injection preferences, and lifestyle factors all contribute to personalised treatment recommendations. Some patients may respond better to single-hormone GLP-1 therapy, whilst others might benefit from dual-hormone approaches.
EverydayMeds prescribers provide comprehensive guidance on dose escalation timing, side effect management, and when to consider treatment switches. The flexibility of online prescription services means you can access both options through the same clinical team, ensuring continuity of care throughout your weight management journey. Regular check-ins and dose adjustments can be managed efficiently through digital consultations, maintaining therapeutic progress without disrupting your routine or requiring multiple healthcare provider relationships.
Start Your Wegovy V Mounjaro Doses Journey Today
Both Wegovy and Mounjaro represent significant advances in prescription weight management, each offering distinct mechanisms and dosing approaches suitable for different patient profiles. EverydayMeds provides access to both treatments through our streamlined online prescription service, ensuring you receive expert clinical guidance regardless of which medication suits your needs. New customers use discount code FIRST40 at checkout, whilst returning customers apply DOSE25 for continued savings. Our clinical team, operating through GPhC-registered pharmacy #9012878, ensures every prescription meets the highest standards of pharmaceutical care and regulatory compliance. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discover which treatment option aligns best with your weight management goals alongside reduced-calorie diet and increased physical activity.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
